U.S. opens tariff probe targeting Germany’s drug pricing policies

The U.S. has launched an investigation into Germany’s pharma policies over what it referred to as “persistent underpayment” for medicines as the European country looks to limit spiraling healthcare costs, including spending on drugs.  “President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development,”…

Read More

Lilly, Novo, Pfizer look to new weight loss drugs

Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even so, they’re already outlining their visions for the future of obesity drugs. At the American Diabetes Association’s Scientific Sessions in New Orleans last week, drugmakers pitched doctors and investors on the idea of new shots…

Read More

Trump tariffs fall, but trade war impacts linger

A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some companies are still feeling the effects. While some industries have emerged largely unscathed — having weathered twists and turns of several tariff iterations — others, such as retail, automotive,…

Read More

Women defying odds to reach highest success level

The third annual CNBC Changemakers list of women transforming business and philanthropy, which launched on Wednesday, recognizes leaders at the forefront of AI and innovators across traditional fields, from finance to healthcare, retail, entertainment and sports. The 2026 Changemakers range from startup founders to high-profile stars such as Kim Kardashian, who grew Skims to a…

Read More